Instituto Rosenbusch S.A. (ROSE) - Cash Flow Conversion Efficiency

Latest as of December 2025: -1.542x

Based on the latest financial reports, Instituto Rosenbusch S.A. (ROSE) has a cash flow conversion efficiency ratio of -1.542x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AR$811.18 Million ≈ $586.98K USD) by net assets (AR$-526.19 Million ≈ $-380.75K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Instituto Rosenbusch S.A. for the company's overall valuation and market capitalisation.

Instituto Rosenbusch S.A. - Cash Flow Conversion Efficiency Trend (2000–2025)

This chart illustrates how Instituto Rosenbusch S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Instituto Rosenbusch S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Instituto Rosenbusch S.A. ranked by their cash flow conversion efficiency. Explore Instituto Rosenbusch S.A. (ROSE) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
NASDAQ:HKPD
-0.053x
BuilderSmart Public Company Limited
BK:BSM
0.083x
IQE PLC
LSE:IQE
0.005x
Custodian REIT PLC
LSE:CREI
0.025x
Jowell Global Ltd.
NASDAQ:JWEL
-0.494x
Binect AG
XETRA:MA10
0.012x
Massivit 3D Printing Technologies Ltd
TA:MSVT
-0.392x
Wishpond Technologies Ltd
V:WISH
-0.061x

Annual Cash Flow Conversion Efficiency for Instituto Rosenbusch S.A. (2000–2025)

The table below shows the annual cash flow conversion efficiency of Instituto Rosenbusch S.A. from 2000 to 2025. View Instituto Rosenbusch S.A. share price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 AR$-526.19 Million
≈ $-380.75K
AR$409.89 Million
≈ $296.60K
-0.779x -531.50%
2024-12-31 AR$3.99 Billion
≈ $2.89 Million
AR$720.31 Million
≈ $521.22K
0.181x +147.75%
2023-12-31 AR$4.55 Billion
≈ $3.29 Million
AR$331.37 Million
≈ $239.78K
0.073x -40.74%
2022-12-31 AR$400.51 Million
≈ $289.81K
AR$49.25 Million
≈ $35.64K
0.123x -58.04%
2021-12-31 AR$199.19 Million
≈ $144.13K
AR$58.37 Million
≈ $42.24K
0.293x -34.20%
2020-12-31 AR$147.69 Million
≈ $106.87K
AR$65.78 Million
≈ $47.60K
0.445x -13.10%
2019-12-31 AR$115.52 Million
≈ $83.59K
AR$59.20 Million
≈ $42.84K
0.513x +439.11%
2018-12-31 AR$145.95 Million
≈ $105.61K
AR$-22.06 Million
≈ $-15.96K
-0.151x -272.55%
2017-12-31 AR$86.58 Million
≈ $62.65K
AR$-3.51 Million
≈ $-2.54K
-0.041x -121.32%
2016-12-31 AR$83.24 Million
≈ $60.23K
AR$15.84 Million
≈ $11.46K
0.190x +252.20%
2015-12-31 AR$70.62 Million
≈ $51.10K
AR$-8.83 Million
≈ $-6.39K
-0.125x -192.60%
2014-12-31 AR$68.24 Million
≈ $49.38K
AR$9.21 Million
≈ $6.67K
0.135x -32.36%
2011-12-31 AR$56.25 Million
≈ $40.70K
AR$11.23 Million
≈ $8.12K
0.200x +96.02%
2010-12-31 AR$50.20 Million
≈ $36.32K
AR$5.11 Million
≈ $3.70K
0.102x +352.72%
2009-12-31 AR$46.95 Million
≈ $33.97K
AR$1.06 Million
≈ $764.13
0.022x -87.71%
2008-12-31 AR$45.65 Million
≈ $33.03K
AR$8.36 Million
≈ $6.05K
0.183x +811.58%
2007-12-31 AR$37.50 Million
≈ $27.13K
AR$753.00K
≈ $544.87
0.020x -65.96%
2006-12-31 AR$35.97 Million
≈ $26.03K
AR$2.12 Million
≈ $1.54K
0.059x -61.58%
2005-12-31 AR$34.13 Million
≈ $24.70K
AR$5.24 Million
≈ $3.79K
0.154x -9.98%
2003-12-31 AR$28.27 Million
≈ $20.45K
AR$4.82 Million
≈ $3.49K
0.171x +122.37%
2002-12-31 AR$24.17 Million
≈ $17.49K
AR$1.85 Million
≈ $1.34K
0.077x +268.10%
2000-12-31 AR$11.90 Million
≈ $8.61K
AR$248.00K
≈ $179.45
0.021x --

About Instituto Rosenbusch S.A.

BA:ROSE Argentina Drug Manufacturers - Specialty & Generic
Market Cap
$4.78 Million
AR$6.60 Billion ARS
Market Cap Rank
#28774 Global
#77 in Argentina
Share Price
AR$155.00
Change (1 day)
+1.64%
52-Week Range
AR$119.50 - AR$327.00
All Time High
AR$380.00
About

Instituto Rosenbusch S.A. manufactures and sells veterinary products in Argentina. The company offers biological products, including products for reproductive-respiratory complex, IBR, BVD, brucelosis, carbuncle, and other diseases; clostridial vaccines; vaccines for cattle, sheep, goats, horses, and dogs; and products for the prevention of pneumonia and calve diarrhea, and cattle infectious kera… Read more